NCIt definition : An orally available, selective estrogen receptor degrader (SERD), with antineoplastic
activity. Upon oral administration, elacestrant acts as a SERD, which binds to the
estrogen receptor (ER) and induces a conformational change that results in the proteosomal
degradation of the receptor. This prevents ER-mediated signaling and inhibits proliferation
of ER-expressing cancer cells.;
UNII : FM6A2627A8;
InChIKey : SIFNOOUKXBRGGB-AREMUKBSSA-N;
CAS number : 722533-56-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 722533-56-4
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;